← All companies

ADPT

Adaptive Biotechnologies Corporation

ADPT Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$23.11

-1.07 -4.43%

Key statistics

from XBRL data in SEC filings

Market cap

$3.70B

Revenue (TTM)

$295M

Net income (TTM)

-$49.7M

EPS (TTM)

$-0.32

P/E ratio

—

Dividend yield

—

Free cash flow

-$48.9M

Cash

$77.6M

Total assets

$506M

Gross margin

—

52-week range

$10.19 – $24.57

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release); Director or officer change Jul 29, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Jun 22, 2026 8-K Other events Jun 15, 2026 8-K Shareholder vote results Jun 9, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 5, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Other events Dec 30, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Terminated a material agreement Aug 18, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Shareholder vote results Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Feb 11, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Shareholder vote results; Other events Jun 11, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Director or officer change Apr 9, 2024 8-K Results of operations (earnings release) Apr 5, 2024 8-K Director or officer change Apr 2, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 14, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 8-K Director or officer change Sep 1, 2023 10-Q Quarter ended 2023-06-30 Aug 2, 2023 8-K Results of operations (earnings release); Director or officer change Aug 2, 2023 8-K Delisting notice or listing-rule failure Jul 3, 2023 8-K Director or officer change; Shareholder vote results Jun 13, 2023 8-K Regulation FD disclosure; Other events May 9, 2023